2019-07-25T11:01:00
(BPT) – People diagnosed with cancer face many questions about the right treatment for their individual disease. Genomic Health has developed its Oncotype DX® genomic-based diagnostic tests to help guide treatment options for breast, colon and prostate cancers. These tests are transforming the quality of cancer care by helping patients receive life-saving treatment while avoiding unnecessary treatment — resulting in improved patient outcomes and reduced healthcare costs. Visit www.OncotypeIQ.com/healthcaresavings to learn more about how these tests can help guide treatment decisions and whether they might be suitable for you or your loved one with cancer.
